Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.96 |
| ▸ | HRH4 | Q9H3N8 | 5/20 | 0.88 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.88 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.88 |
| ▸ | HRH2 | P25021 | 1/20 | 0.88 |
| ▸ | NOS1 | P29475 | 6/20 | 0.56 |
| ▸ | NOS3 | P29474 | 4/20 | 0.56 |
| ▸ | NOS2 | P35228 | 4/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7367775 | 0.98 | ALDH1A1 (1.00) | HSD17B10ALDH1A1HRH4CYP1A2TDP1 | |
| Dimaprit SCHEMBL379810 | 0.93 | HRH4 (1.00) | HSD17B10ALDH1A1HRH4CYP1A2TDP1 | |
| Dimaprit SCHEMBL7173650 | 0.91 | HRH4 (1.00) | HSD17B10ALDH1A1HRH4CYP1A2TDP1 | |
| Dimaprit SCHEMBL7174665 | 0.91 | HRH4 (0.96) | HSD17B10ALDH1A1HRH4CYP1A2TDP1 | |
| Dimaprit SCHEMBL30836911 | 0.91 | HRH4 (0.96) | HSD17B10ALDH1A1HRH4CYP1A2TDP1 | |
| SCHEMBL7216548 | 0.84 | — | — | |
| Hydrochloric Acid SCHEMBL3588464 | 0.82 | ALDH1A1 (0.73) | HSD17B10ALDH1A1HRH4CYP1A2TDP1 | |
| SCHEMBL9193111 | 0.78 | CYP1A2 (0.71) | HSD17B10ALDH1A1HRH4CYP1A2TDP1 | |
| SCHEMBL6216529 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL7176136 | 0.74 | HRH4 (0.66) | HSD17B10ALDH1A1HRH4CYP1A2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2024229174-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2024-11-07 | — | — | WO | claimed |
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024229174-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2024-11-07 | — | — | WO | disclosed |
| US-20230201246-A1 | METAL COMPOSITIONS AND METHODS OF USE THEREOF | UNIVERSITY OF MASSACHUSETTS | 2023-06-29 | — | — | US | disclosed |
| US-20230201246-A1 | METAL COMPOSITIONS AND METHODS OF USE THEREOF | UNIVERSITY OF MASSACHUSETTS | 2023-06-29 | — | — | US | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-9034798-B2 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | CAPROTEC BIOANALYTICS GMBH (DE) | 2015-05-19 | — | — | US | disclosed |
| US-8569481-B2 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | PHARMACEUTICALS, INC. (US) | 2013-10-29 | — | — | US | disclosed |
| US-20110118136-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | KOESTER HUBERT | 2011-05-19 | — | — | US | disclosed |
| US-20100298168-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | HK PHARMACEUTICALS, INC. | 2010-11-25 | — | — | US | disclosed |
| US-20100248264-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | HK PHARMACEUTICALS, INC. | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230201246-A1 | METAL COMPOSITIONS AND METHODS OF USE THEREOF | SOD1, SOD3, SLC30A5 | HSD17B10 4636/4885ALDH1A1 4374/4885HRH4 1770/4885 |
| US-20110118136-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | PTMS, QPCTL, SRMS | HSD17B10 4450/4885ALDH1A1 4360/4885HRH4 4303/4885 |
| US-20100298168-A1 | Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions | CHLSN, PTMS, SRMS | HSD17B10 2950/4885ALDH1A1 4064/4885HRH4 4411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.